(02) 9926 4726

News and Event

Clinical Trial: Participants with advanced cancer, no curative treatment options

Prof Stan Sidhu (Professor of Surgery, Head of the University of Sydney Endocrine Surgical Unit) and his team have conducted a clinical trial; A study of EnGeneIC Dream Vectors (EDV’s) packaged with the chemotherapy PNU-159682, given simultaneously as non-targeted EDVs carrying an immune enhancer called EDVs40-mer, in participants with advanced cancer who have no curative treatment options.

Trail ID: ACTRN12617000037303


Post a comment